MRC1 and type 2 diabetes mellitus: At the early stage of diabetes (1 week after STZ administration), the flow cytometry results revealed that macrophages in KO-T2D hearts exhibited a more robust pro-inflammatory signature, as evidenced by a higher ratio of Ly6C+ population to CD206+ population compared to WT-T2Ds (Figures 4A–D).